Outcomes of postoperative adjuvant transarterial chemoembolization for hepatocellular carcinoma according to the Ki67 index

References

• Bruix Jordi , GoresGJ, MazzaferroV. Hepatocellular carcinoma: clinical frontiers and perspectives. Gut63(5), 844–855 (2014).
   PubMed Web of Science ®Google Scholar
• Sahu SK , ChawlaYK, DhimanRKet al. Rupture of hepatocellular carcinoma: a review of literature. J. Clin. Exp. Hepatol.9(2), 245–256 (2019).
   PubMed Web of Science ®Google Scholar
• Jian-Hong Z , ChapinRA, YangK, Yan-YanW, LinW, Le-QunL. Hepatic resection as a safe and effective treatment for hepatocellular carcinoma involving a single large tumor, multiple tumors, or macrovascular invasion. Medicine94(3), e396 (2015).
   PubMed Web of Science ®Google Scholar
• Tabrizian Parissa , GhalibJibaraet al. Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis. Ann. Surg.261(5), 947–955 (2015).
   PubMed Web of Science ®Google Scholar
• Cucchetti A , PiscagliaF, CesconM, ErcolaniG, PinnaAD. Conditional survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients. Clin. Cancer Res.18(16), 4397–4405 (2012).
   PubMed Web of Science ®Google Scholar
• Hui X , WangH, AnWet al. The efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization for primary hepatocellular carcinoma in a cohort of 487 patients. PLoS ONE9(2), e89081 (2014).
   PubMed Web of Science ®Google Scholar
• Li N , FengS, XueJet al. Hepatocellular carcinoma with main portal vein tumor thrombus: a comparative study comparing hepatectomy with or without neoadjuvant radiotherapy. HPB (Oxford)18(6), 549–556 (2016).
   PubMed Web of Science ®Google Scholar
• Liao M , ZhuZ, WangH, HuangJ. Adjuvant transarterial chemoembolization for patients after curative resection of hepatocellular carcinoma: a meta-analysis. Scand. J. Gastroenterol.52(6-7), 624–634 (2017).
   PubMed Web of Science ®Google Scholar
• He S , FanX, MaHet al. Effect of prophylactic TACE on 5-year survival of patients with hepatocellular carcinoma after hepatectomy. Oncol. Lett.18(2), 1824–1830 (2019).
   PubMed Web of Science ®Google Scholar
• Qi YP , Zhong JH, Liang ZYet al. Adjuvant transarterial chemoembolization for patients with hepatocellular carcinoma involving microvascular invasion. Am. J. Surg.217(4), 739–744 (2019).
   PubMed Web of Science ®Google Scholar
• Xu D , LiuX, WangL, XingB. Hepatectomy plus adjuvant transcatheter arterial chemoembolization improves the survival rate of patients with multicentric occurrence of hepatocellular carcinoma. Oncol. Lett.16(5), 5882–5890 (2018).
   PubMed Web of Science ®Google Scholar
• Wang JH , FangZT, WangGZet al. Transcatheter arterial embolization promotes liver tumor metastasis by increasing the population of circulating tumor cells. Onco. Targets Ther.6, 1563–1572 (2013).
   PubMed Web of Science ®Google Scholar
• Chen W , MaT, ZhangJ, ZhangX, LiangT. A systematic review and meta-analysis of adjuvant transarterial chemoembolization after curative resection for patients with hepatocellular carcinoma. HPB (Oxford)22(6), 795–808 (2020).
   PubMed Web of Science ®Google Scholar
• Sun X , KaufmanPD. Ki-67: more than a proliferation marker. Chromosoma127(2), 175–186 (2018).
   PubMed Web of Science ®Google Scholar
• Li LT , JiangG, ChenQ, ZhengJN. Ki67 is a promising molecular target in the diagnosis of cancer (review). Mol. Med. Rep.11(3), 1566–1572 (2015).
   PubMed Web of Science ®Google Scholar
• Sorbye SW , KilvaerTK, AndrejVet al. Prognostic impact of Jab1, p16, p21, p62, Ki67 and Skp2 in soft tissue sarcomas. PLoS ONE7(10), e47068 (2012).
   PubMed Web of Science ®Google Scholar
• Ciancio N , GalassoMG, CampisiR, BivonaL, MiglioreM, MariaGUD. Prognostic value of p53 and Ki67 expression in fiberoptic bronchial biopsies of patients with non small cell lung cancer. Multi. Resp. Med.7, 29 (2012).
   Google Scholar
• Li HH , QiLN, MaL, ChenZS, XiangBD, LiLQ. Effect of KI-67 positive cellular index on prognosis after hepatectomy in Barcelona Clinic Liver Cancer stage A and B hepatocellular carcinoma with microvascular invasion. Onco. Targets Ther.11, 4747–4754 (2018).
   PubMed Web of Science ®Google Scholar
• Chien-Hung C , Ting-TsungC, Ken-ShengCet al. Do young hepatocellular carcinoma patients have worse prognosis? The paradox of age as a prognostic factor in the survival of hepatocellular carcinoma patients. Liver Int.26(7), 766–773 (2006).
   PubMed Web of Science ®Google Scholar
• Zhong JH , XiangBD, GongWFet al. Correction: comparison of long-term survival of patients with BCLC stage B hepatocellular carcinoma after liver resection or transarterial chemoembolization. PLoS ONE9(1), (2014).
   Google Scholar
• Zhong JH , KeY, GongWFet al. Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma. Ann. Surg.260(2), 329–340 (2014).
   PubMed Web of Science ®Google Scholar
• Gao Z , DuG, PangYet al. Adjuvant transarterial chemoembolization after radical resection contributed to the outcomes of hepatocellular carcinoma patients with high-risk factors. Medicine96(33), e7426 (2017).
   PubMed Web of Science ®Google Scholar
• Inari H , SuganumaN, KawachiKet al. Clinicopathological and prognostic significance of Ki-67 immunohistochemical expression of distant metastatic lesions in patients with metastatic breast cancer. Breast Cancer24(6), 748–755 (2017).
   PubMed Web of Science ®Google Scholar
• Modi TG , ChalishazarM, KumarM. Expression of Ki-67 in odontogenic cysts: a comparative study between odontogenic keratocysts, radicular cysts and dentigerous cysts. J. Oral Maxillofac. Pathol.22(1), 146–146 (2018).
   PubMedGoogle Scholar
• Ahmed A , Al-TamimiDM. Incorporation of p-53 mutation status and Ki-67 proliferating index in classifying Her2-neu positive gastric adenocarcinoma. Libyan J. Med.13(1), 1466573 (2018).
   PubMedGoogle Scholar
• Zhao YF , XiongX, ChenK, TangW, YangX, ShiZR. Evaluation of the therapeutic effect of adjuvant transcatheter arterial chemoembolization based on Ki67 after hepatocellular carcinoma surgery. Front. Oncol.11, 605234 (2021).
   PubMed Web of Science ®Google Scholar
• Thomas Scholzen , JohannesGerdes. The Ki-67 protein: from the known and the unknown. J. Cell. Physiol.182(3), 311–322 (2000).
   PubMed Web of Science ®Google Scholar
• Robles AI , HuangC. Integrated proteogenomic characterization of HBV-related hepatocellular carcinoma. Cell179(2), 561–577 (2019).
   PubMed Web of Science ®Google Scholar
• Cidado J , HongYW, RosenDM, Imino-MathewsAC, ParkBH. Ki-67 is required for maintenance of cancer stem cells but not cell proliferation. Oncotarget7(5), 6281–6293 (2016).
   PubMedGoogle Scholar
• Mrouj K , Andrés-SánchezN, DubraG, SinghP, FisherD. Ki-67 regulates global gene expression and promotes sequential stages of carcinogenesis. Proc. Natl. Acad. Sci. USA118(10), e2026507118 (2021).
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research Network . Comprehensive and integrative genomic characterization of hepatocellular carcinoma. Cell169(7), 1327–1341.e1323 (2017).
   PubMed Web of Science ®Google Scholar
• Su CW , LeiHJ, ChauGYet al. The effect of age on the long-term prognosis of patients with hepatocellular carcinoma after resection surgery: a propensity score matching analysis. Arch. Surg.147(2), 137–144 (2012).
   PubMedGoogle Scholar
• Xu XS , ChenW, MiaoRCet al. Survival analysis of hepatocellular carcinoma: a comparison between young patients and aged patients. Chin. Med. J.128(13), 1793–1800 (2015).
   PubMed Web of Science ®Google Scholar
• Lam CM , ChanAO, HoPet al. Different presentation of hepatitis B-related hepatocellular carcinoma in a cohort of 1863 young and old patients – implications for screening. Aliment. Pharmacol. Ther.19(7), 771–777 (2004).
   PubMed Web of Science ®Google Scholar